The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings

References

• Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N. Engl. J. Med.298(10), 531–534 (1978).
   PubMed Web of Science ®Google Scholar
• Campbell RJ, Giljahn L, Machesky K et al. Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect. Control Hosp. Epidemiol.30(6), 526–533 (2009).
   PubMed Web of Science ®Google Scholar
• Dallal RM, Harbrecht BG, Boujoukas AJ et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann. Surg.235(3), 363–372 (2002).
   PubMed Web of Science ®Google Scholar
• Loo VG, Poirier L, Miller MA et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med.353(23), 2442–2449 (2005).
   PubMed Web of Science ®Google Scholar
• McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg. Infect. Dis.12(3), 409–415 (2006).
   PubMed Web of Science ®Google Scholar
• Muto CA, Pokrywka M, Shutt K et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect. Control Hosp. Epidemiol.26(3), 273–280 (2005).
   PubMed Web of Science ®Google Scholar
• Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ173(9), 1037–1042 (2005).
   PubMed Web of Science ®Google Scholar
• Zilberberg MD. Clostridium difficile-related hospitalizations among US adults, 2006. Emerg. Infect. Dis.15(1), 122–124 (2009).
   PubMed Web of Science ®Google Scholar
• Zilberberg MD, Shorr AF, Kollef MH. Increase in Clostridium difficile-related hospitalizations among infants in the United States, 2000–2005. Pediatr. Infect. Dis. J.27(12), 1111–1113 (2008).
   PubMed Web of Science ®Google Scholar
• Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch. Surg.142(7), 624–631; discussion 631 (2007).
   PubMed Web of Science ®Google Scholar
• Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and case–fatality rate, United States, 2000–2005. Emerg. Infect. Dis.14(6), 929–931 (2008).
   PubMed Web of Science ®Google Scholar
• Pepin J, Alary ME, Valiquette L et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin. Infect. Dis.40(11), 1591–1597 (2005).
   PubMed Web of Science ®Google Scholar
• Pepin J, Valiquette L, Alary ME et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ171(5), 466–472 (2004).
   PubMed Web of Science ®Google Scholar
• Gould M. Number of C. difficile cases rises. BMJ333(7561), 215 (2006).
   PubMed Web of Science ®Google Scholar
• Asensio A, Vaque-Rafart J, Calbo-Torrecillas F et al. Increasing rates in Clostridium difficile infection (CDI) among hospitalised patients, Spain 1999–2007. Euro Surveill.13(31) 18943 (2008).
   PubMedGoogle Scholar
• Bacci S, St-Martin G, Olesen B et al. Outbreak of Clostridium difficile 027 in North Zealand, Denmark, 2008–2009. Euro Surveill.14(16) 19183 (2009).
   PubMedGoogle Scholar
• Borgmann S, Kist M, Jakobiak T et al. Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany. Euro Surveill.13(49) 19057 (2008).
   PubMedGoogle Scholar
• Burckhardt F, Friedrich A, Beier D, Eckmanns T. Clostridium difficile surveillance trends, Saxony, Germany. Emerg. Infect. Dis.14(4), 691–692 (2008).
   PubMed Web of Science ®Google Scholar
• Graf K, Cohrs A, Gastmeier P et al. An outbreak of Clostridium difficile-associated disease (CDAD) in a German university hospital. Eur. J. Clin. Microbiol. Infect. Dis.28(5), 543–545 (2009).
   PubMed Web of Science ®Google Scholar
• Joseph R, Demeyer D, Vanrenterghem D, van den Berg R, Kuijper E, Delmee M. First isolation of Clostridium difficile PCR ribotype 027, toxinotype III in Belgium. Euro Surveill.10(10), E051020.4 (2005).
   PubMedGoogle Scholar
• Lambert ML, Mertens K, Ramboer I, Delmee M, Suetens C. Nation-wide prospective surveillance of Clostridium difficile infections in hospitals in Belgium, July 2007–June 2008. Euro Surveill.14(14), 2–4 (2009).
   PubMedGoogle Scholar
• Lyytikainen O, Turunen H, Sund R et al. Hospitalizations and deaths associated with Clostridium difficile infection, Finland, 1996–2004. Emerg. Infect. Dis.15(5), 761–765 (2009).
   PubMed Web of Science ®Google Scholar
• Soler P, Nogareda F, Cano R. Rates of Clostridium difficile infection in patients discharged from Spanish hospitals, 1997–2005. Infect. Control Hosp. Epidemiol.29(9), 887–889 (2008).
   PubMed Web of Science ®Google Scholar
• van den Hof S, van der Kooi T, van den Berg R, Kuijper EJ, Notermans DW. Clostridium difficile PCR ribotype 027 outbreaks in The Netherlands: recent surveillance data indicate that outbreaks are not easily controlled but interhospital transmission is limited. Euro Surveill.11(1), E060126.2 (2006).
   PubMedGoogle Scholar
• Gravel D, Miller M, Simor A et al. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin. Infect. Dis.48(5), 568–576 (2009).
   PubMed Web of Science ®Google Scholar
• Archibald LK, Banerjee SN, Jarvis WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987–2001. J. Infect. Dis.189(9), 1585–1589 (2004).
   PubMed Web of Science ®Google Scholar
• Salazar M, Baskin L, Garey KW, DuPont HL. Clostridium difficile-related death rates in Texas 1999–2005. J. Infect.59(5), 303–307 (2009).
   PubMed Web of Science ®Google Scholar
• Kelly CP, LaMont JT. Clostridium difficile – more difficult than ever. N. Engl. J. Med.359(18), 1932–1940 (2008).
   PubMed Web of Science ®Google Scholar
• Morris AM, Jobe BA, Stoney M, Sheppard BC, Deveney CW, Deveney KE. Clostridium difficile colitis: an increasingly aggressive iatrogenic disease? Arch. Surg.137(10), 1096–1100 (2002).
   PubMedGoogle Scholar
• Kelly CP, LaMont JT. Clostridium difficile infection. Annu. Rev. Med.49, 375–390 (1998).
   PubMed Web of Science ®Google Scholar
• Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC. Clostridium difficile colitis: an increasing hospital-acquired illness. Am. J. Surg.169(5), 480–483 (1995).
   PubMed Web of Science ®Google Scholar
• Karlstrom O, Fryklund B, Tullus K, Burman LG. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin. Infect. Dis.26(1), 141–145 (1998).
   PubMed Web of Science ®Google Scholar
• Goorhuis A, Van der Kooi T, Vaessen N et al. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin. Infect. Dis.45(6), 695–703 (2007).
   PubMed Web of Science ®Google Scholar
• McDonald LC, Killgore GE, Thompson A et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med.353(23), 2433–2441 (2005).
   PubMed Web of Science ®Google Scholar
• McFarland LV, Clarridge JE, Beneda HW, Raugi GJ. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system. Clin. Infect. Dis.45(9), 1141–1151 (2007).
   PubMed Web of Science ®Google Scholar
• Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A case–control study of community-associated Clostridium difficile infection. J. Antimicrob. Chemother.62(2), 388–396 (2008).
   PubMed Web of Science ®Google Scholar
• Frost F, Hurley JS, Petersen HV, Casciano RN. Estimated incidence of Clostridium difficile infection. Emerg. Infect. Dis.5(2), 303–304 (1999).
   PubMed Web of Science ®Google Scholar
• Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA294(23), 2989–2995 (2005).
   PubMed Web of Science ®Google Scholar
• Beaugerie L, Flahault A, Barbut F et al. Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment. Pharmacol. Ther.17(7), 905–912 (2003).
   PubMed Web of Science ®Google Scholar
• Noren T, Akerlund T, Back E et al. Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J. Clin. Microbiol.42(8), 3635–3643 (2004).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Severe Clostridium difficile-associated disease in populations previously at low risk – four states, 2005. MMWR Morb. Mortal. Wkly Rep.54(47), 1201–1205 (2005).
   PubMedGoogle Scholar
• Khanna S, Aronson SL, Kammer PP, Orenstein R, Pardi DS. Comparison between community acquired and hospital acquired Clostridium difficile infection: a population-based study. Am. J. Gastroenterol.104(S3), S183 (2009).
   Google Scholar
• Bauer MP, Goorhuis A, Koster T et al. Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage – two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea. Neth. J. Med.66(5), 207–211 (2008).
   PubMed Web of Science ®Google Scholar
• Dial S, Kezouh A, Dascal A, Barkun A, Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ179(8), 767–772 (2008).
   PubMed Web of Science ®Google Scholar
• Hubert B, Gilca R. Use administrative databases with caution. CMAJ180(1), 78; author reply 78–79 (2009).
   PubMed Web of Science ®Google Scholar
• Hirschhorn LR, Trnka Y, Onderdonk A, Lee ML, Platt R. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J. Infect. Dis.169(1), 127–133 (1994).
   PubMed Web of Science ®Google Scholar
• Rupnik M. Is Clostridium difficile-associated infection a potentially zoonotic and foodborne disease? Clin. Microbiol. Infect.13(5), 457–459 (2007).
   PubMed Web of Science ®Google Scholar
• Jhung MA, Thompson AD, Killgore GE et al. Toxinotype V Clostridium difficile in humans and food animals. Emerg. Infect. Dis.14(7), 1039–1045 (2008).
   PubMed Web of Science ®Google Scholar
• Weese JS. Clostridium difficile in food – innocent bystander or serious threat? Clin. Microbiol. Infect.16(1), 3–10 (2010).
   PubMed Web of Science ®Google Scholar
• Indra A, Lassnig H, Baliko N et al. Clostridium difficile: a new zoonotic agent? Wien. Klin. Wochenschr.121(3–4), 91–95 (2009).
   PubMed Web of Science ®Google Scholar
• Weese JS, Avery BP, Rousseau J, Reid-Smith RJ. Detection and enumeration of Clostridium difficile spores in retail beef and pork. Appl. Environ. Microbiol.75(15), 5009–5011 (2009).
   PubMed Web of Science ®Google Scholar
• Keel MK, Songer JG. The distribution and density of Clostridium difficile toxin receptors on the intestinal mucosa of neonatal pigs. Vet. Pathol.44(6), 814–822 (2007).
   PubMed Web of Science ®Google Scholar
• Keel K, Brazier JS, Post KW, Weese S, Songer JG. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J. Clin. Microbiol.45(6), 1963–1964 (2007).
   PubMed Web of Science ®Google Scholar
• Avbersek J, Janezic S, Pate M et al. Diversity of Clostridium difficile in pigs and other animals in Slovenia. Anaerobe15(6), 252–255 (2009).
   PubMed Web of Science ®Google Scholar
• Pirs T, Ocepek M, Rupnik M. Isolation of Clostridium difficile from food animals in Slovenia. J. Med. Microbiol.57(Pt 6), 790–792 (2008).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Palacios A, Stampfli HR, Duffield T et al. Clostridium difficile PCR ribotypes in calves, Canada. Emerg. Infect. Dis.12(11), 1730–1736 (2006).
   PubMed Web of Science ®Google Scholar
• Jobstl M, Heuberger S, Indra A, Nepf R, Kofer J, Wagner M. Clostridium difficile in raw products of animal origin. Int. J. Food Microbiol.138(1–2), 172–175 (2010).
   PubMed Web of Science ®Google Scholar
• Weese JS, Reid-Smith RJ, Avery BP, Rousseau J. Detection and characterization of Clostridium difficile in retail chicken. Lett. Appl. Microbiol.50(4), 362–365 (2010).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Palacios A, Reid-Smith RJ, Staempfli HR et al. Possible seasonality of Clostridium difficile in retail meat, Canada. Emerg. Infect. Dis.15(5), 802–805 (2009).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Palacios A, Staempfli HR, Duffield T, Weese JS. Clostridium difficile in retail ground meat, Canada. Emerg. Infect. Dis.13(3), 485–487 (2007).
   PubMed Web of Science ®Google Scholar
• Songer JG, Trinh HT, Killgore GE, Thompson AD, McDonald LC, Limbago BM. Clostridium difficile in retail meat products, USA, 2007. Emerg. Infect. Dis.15(5), 819–821 (2009).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Palacios A, Reid-Smith RJ, Staempfli HR, Weese JS. Clostridium difficile survives minimal temperature recommended for cooking ground meats. Anaerobe DOI:10.1016/j.anaerobe. 2010.05.004 (2010) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Freeman J, Wilcox MH. The effects of storage conditions on viability of Clostridium difficile vegetative cells and spores and toxin activity in human faeces. J. Clin. Pathol.56(2), 126–128 (2003).
   PubMed Web of Science ®Google Scholar
• Gastmeier P, Weitzel-Kage D, Behnke M, Eckmanns T. Surveillance of Clostridium difficile-associated diarrhoea with the German nosocomial infection surveillance system KISS (CDAD-KISS). Int. J. Antimicrob. Agents33(Suppl. 1), S19–S23 (2009).
   Google Scholar
• Fraser TG, Fatica C, Gordon SM. Necessary but not sufficient: a comparison of surveillance definitions of Clostridium difficile-associated diarrhea. Infect. Control Hosp. Epidemiol.30(4), 377–379 (2009).
   PubMed Web of Science ®Google Scholar
• Shears P, Prtak L, Duckworth R. Hospital-based epidemiology: a strategy for ‘dealing with Clostridium difficile’. J. Hosp. Infect.74(4), 319–325 (2010).
   PubMed Web of Science ®Google Scholar
• McDonald LC, Coignard B, Dubberke E et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect. Control Hosp. Epidemiol.28(2), 140–145 (2007).
   PubMed Web of Science ®Google Scholar
• Lambert PJ, Dyck M, Thompson LH, Hammond GW. Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions. Infect. Control Hosp. Epidemiol.30(10), 945–951 (2009).
   PubMed Web of Science ®Google Scholar
• Kutty PK, Benoit SR, Woods CW et al. Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005. Infect. Control Hosp. Epidemiol.29(3), 197–202 (2008).
   PubMed Web of Science ®Google Scholar
• Dubberke ER, McMullen KM, Mayfield JL et al. Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease? Infect. Control Hosp. Epidemiol.30(4), 332–337 (2009).
   PubMed Web of Science ®Google Scholar
• Dubberke ER, Butler AM, Hota B et al. Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection. Infect. Control Hosp. Epidemiol.30(6), 518–525 (2009).
   PubMed Web of Science ®Google Scholar
• Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T. Epidemiological features of Clostridium difficile-associated disease among inpatients at children’s hospitals in the United States, 2001–2006. Pediatrics122(6), 1266–1270 (2008).
   PubMed Web of Science ®Google Scholar
• Klein EJ, Boster DR, Stapp JR et al. Diarrhea etiology in a Children’s Hospital Emergency Department: a prospective cohort study. Clin. Infect. Dis.43(7), 807–813 (2006).
   PubMed Web of Science ®Google Scholar
• Morinville V, McDonald J. Clostridium difficile-associated diarrhea in 200 Canadian children. Can. J. Gastroenterol.19(8), 497–501 (2005).
   PubMed Web of Science ®Google Scholar
• Rexach CE, Tang-Feldman YJ, Cohen SH. Spatial and temporal analysis of Clostridium difficile infection in patients at a pediatric hospital in California. Infect. Control Hosp. Epidemiol.26(8), 691–696 (2005).
   PubMed Web of Science ®Google Scholar
• Rouphael NG, O’Donnell JA, Bhatnagar J et al.Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am. J. Obstet. Gynecol.198(6), 635 e1–e6 (2008).
   PubMed Web of Science ®Google Scholar
• Rodemann JF, Dubberke ER, Reske KA, Seo da H, Stone CD. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin. Gastroenterol. Hepatol.5(3), 339–344 (2007).
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut57(2), 205–210 (2008).
   PubMed Web of Science ®Google Scholar
• Nguyen GC, Kaplan GG, Harris ML, Brant SR. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am. J. Gastroenterol.103(6), 1443–1450 (2008).
   PubMed Web of Science ®Google Scholar
• Ricciardi R, Ogilvie JW Jr, Roberts PL, Marcello PW, Concannon TW, Baxter NN. Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases. Dis. Colon Rectum52(1), 40–45 (2009).
   PubMed Web of Science ®Google Scholar
• Clayton EM, Rea MC, Shanahan F et al. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am. J. Gastroenterol.104(5), 1162–1169 (2009).
   PubMed Web of Science ®Google Scholar
• Lumpkins K, Bochicchio GV, Joshi M et al.Clostridium difficile infection in critically injured trauma patients. Surg. Infect. (Larchmt)9(5), 497–501 (2008).
   PubMed Web of Science ®Google Scholar
• Ang CW, Heyes G, Morrison P, Carr B. The acquisition and outcome of ICU-acquired Clostridium difficile infection in a single centre in the UK. J. Infect.57(6), 435–440 (2008).
   PubMed Web of Science ®Google Scholar
• Lawrence SJ, Puzniak LA, Shadel BN, Gillespie KN, Kollef MH, Mundy LM. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect. Control Hosp. Epidemiol.28(2), 123–130 (2007).
   PubMed Web of Science ®Google Scholar
• Henrich TJ, Krakower D, Bitton A, Yokoe DS. Clinical risk factors for severe Clostridium difficile-associated disease. Emerg. Infect. Dis.15(3), 415–422 (2009).
   PubMed Web of Science ®Google Scholar
• Moshkowitz M, Ben-Baruch E, Kline Z, Shimoni Z, Niven M, Konikoff F. Risk factors for severity and relapse of pseudomembranous colitis in an elderly population. Colorectal Dis.9(2), 173–177 (2007).
   PubMed Web of Science ®Google Scholar
• Lamontagne F, Labbe AC, Haeck O et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann. Surg.245(2), 267–272 (2007).
   PubMed Web of Science ®Google Scholar
• Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin. Infect. Dis.45(3), 302–307 (2007).
   PubMed Web of Science ®Google Scholar
• Byrn JC, Maun DC, Gingold DS, Baril DT, Ozao JJ, Divino CM. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch. Surg.143(2), 150–154; discussion 155 (2008).
   PubMed Web of Science ®Google Scholar
• Hall JF, Berger D. Outcome of colectomy for Clostridium difficile colitis: a plea for early surgical management. Am. J. Surg.196(3), 384–388 (2008).
   PubMed Web of Science ®Google Scholar
• Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999–2004. Emerg. Infect. Dis.13(9), 1417–1419 (2007).
   PubMed Web of Science ®Google Scholar
• Song X, Bartlett JG, Speck K, Naegeli A, Carroll K, Perl TM. Rising economic impact of Clostridium difficile-associated disease in adult hospitalized patient population. Infect. Control Hosp. Epidemiol.29(9), 823–828 (2008).
   PubMed Web of Science ®Google Scholar
• Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin. Infect. Dis.34(3), 346–353 (2002).
   PubMed Web of Science ®Google Scholar
• Vonberg RP, Reichardt C, Behnke M, Schwab F, Zindler S, Gastmeier P. Costs of nosocomial Clostridium difficile-associated diarrhoea. J. Hosp. Infect.70(1), 15–20 (2008).
   PubMed Web of Science ®Google Scholar
• Wilcox MH, Cunniffe JG, Trundle C, Redpath C. Financial burden of hospital-acquired Clostridium difficile infection. J. Hosp. Infect.34(1), 23–30 (1996).
   PubMed Web of Science ®Google Scholar
• Miller M, Gravel D, Mulvey M et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin. Infect. Dis.50(2), 194–201 (2010).
   PubMed Web of Science ®Google Scholar
• Warny M, Pepin J, Fang A et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet366(9491), 1079–1084 (2005).
   PubMed Web of Science ®Google Scholar
• Pepin J, Saheb N, Coulombe MA et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin. Infect. Dis.41(9), 1254–1260 (2005).
   PubMed Web of Science ®Google Scholar
• Kyne L, Sougioultzis S, McFarland LV, Kelly CP. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect. Control Hosp. Epidemiol.23(11), 653–659 (2002).
   PubMed Web of Science ®Google Scholar
• Price MF, Dao-Tran T, Garey KW et al. Epidemiology and incidence of Clostridium difficile-associated diarrhoea diagnosed upon admission to a university hospital. J. Hosp. Infect.65(1), 42–46 (2007).
   PubMed Web of Science ®Google Scholar
• Barbut F, Gariazzo B, Bonne L et al. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000–2004. Infect. Control Hosp. Epidemiol.28(2), 131–139 (2007).
   PubMed Web of Science ®Google Scholar
• Dubberke ER, Sadhu J, Gatti R et al. Severity of Clostridium difficile-associated disease (CDAD) in allogeneic stem cell transplant recipients: evaluation of a CDAD severity grading system. Infect. Control Hosp. Epidemiol.28(2), 208–211 (2007).
   PubMed Web of Science ®Google Scholar
• Labbe AC, Poirier L, Maccannell D et al. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob. Agents Chemother.52(9), 3180–3187 (2008).
   PubMed Web of Science ®Google Scholar
• Brazier JS, Raybould R, Patel B et al. Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007–2008. Euro Surveill.13(41) 19000 (2008).
   PubMedGoogle Scholar
• Cheng VC, Yam WC, Chan JF, To KK, Ho PL, Yuen KY. Clostridium difficile ribotype 027 arrives in Hong Kong. Int. J. Antimicrob. Agents34(5), 492–493 (2009).
   PubMed Web of Science ®Google Scholar
• Fenner L, Widmer AF, Stranden A et al. First cluster of clindamycin-resistant Clostridium difficile PCR ribotype 027 in Switzerland. Clin. Microbiol. Infect.14(5), 514–515 (2008).
   PubMed Web of Science ®Google Scholar
• Goorhuis A, Bakker D, Corver J et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis.47(9), 1162–1170 (2008).
   PubMed Web of Science ®Google Scholar
• Indra A, Huhulescu S, Fiedler A, Kernbichler S, Blaschitz M, Allerberger F. Outbreak of Clostridium difficile 027 infection in Vienna, Austria 2008–2009. Euro Surveill.14(17) 19186 (2009).
   PubMedGoogle Scholar
• Indra A, Huhulescu S, Hasenberger P et al. First isolation of Clostridium difficile PCR ribotype 027 in Austria. Euro Surveill.11(9), E060914.3 (2006).
   PubMedGoogle Scholar
• Notermans DW, van der Kooi TI, Goorhuis A, Debast SB, van Benthem BH, Kuijper EJ. [Epidemiology of Clostridium difficile PCR ribotype 027 in The Netherlands 2005–present and the emergence of other subtypes]. Ned. Tijdschr. Geneeskd.152(35), 1937–1940 (2008).
   PubMedGoogle Scholar
• Pituch H, Bakker D, Kuijper E et al. First isolation of Clostridium difficile PCR-ribotype 027/toxinotype III in Poland. Pol. J. Microbiol.57(3), 267–268 (2008).
   PubMed Web of Science ®Google Scholar
• Riley TV, Thean S, Hool G, Golledge CL. First Australian isolation of epidemic Clostridium difficile PCR ribotype 027. Med. J. Aust.190(12), 706–708 (2009).
   PubMed Web of Science ®Google Scholar
• Shin BM, Kuak EY, Yoo HM et al. Multicentre study of the prevalence of toxigenic Clostridium difficile in Korea: results of a retrospective study 2000–2005. J. Med. Microbiol.57(Pt 6), 697–701 (2008).
   PubMed Web of Science ®Google Scholar
• Cloud J, Noddin L, Pressman A, Hu M, Kelly C. Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. Clin. Gastroenterol. Hepatol.7(8), 868–873, e862 (2009).
   PubMed Web of Science ®Google Scholar
• Morgan OW, Rodrigues B, Elston T et al. Clinical severity of Clostridium difficile PCR ribotype 027: a case–case study. PLoS One3(3), e1812 (2008).
   PubMed Web of Science ®Google Scholar
• Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin. Infect. Dis.45(8), 992–998 (2007).
   PubMed Web of Science ®Google Scholar